Why Jin Medical International Ltd.’s (ZJYL) Stock Is Down 10.13%
As of Thursday, October 16, Jin Medical International Ltd.’s ZJYL share price has dipped by 10.13%, which has investors questioning if this is right time to buy.Tudor Pop
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Tudor Pop
Cynthia McLaughlin
Jenna Brashear
Jenna Brashear
Omar Beirat
| Share Statistics | ZJYL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $15.0 | $334.8 | 9% |
|
| Shares Out (Mil) | 7.8 | 41.7 | 18% |
|
| Institutional Ownership | na | 77.3% | na |
|
| Float (Mil) | 1.9 | 34.7 | 5% |
|
| Beta | 7.23 | 0.86 | 100% |
|
| Avg Daily Volume (000s) | 20 | 266 | 21% |
|
| Price Change (52-week) |
(85.6%) | 60.7% | 5% |
|
| Growth | ZJYL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 5.0% | 11.8% | 36% |
|
| Net Income (5yr) | (11.4%) | (5.8%) | 28% |
|
| EPS (5yr) | 6.7% | 10.7% | 41 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (55.2%) | (16.1%) | 5% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ZJYL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $21 | $152 | 13% |
|
| Net Income (TTM) (Mil) | $1 | ($11) | 40% |
|
| EPS (TTM) | $0.152 | ($0.500) | 45% |
|
| Operating Cash Flow (TTM) (Mil) | $3 | ($2) | 35% |
|
| Net Cash Flow (TTM) (Mil) | ($1) | $1 | 41% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $22 | 0% |
|
| Enterprise Value (Q1) (Mil) | $9 | $304 | 7% |
|
| Valuation | ZJYL | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.50 | 2.88 | 9% |
|
| P/E | 12.6 | 30.5 | 26% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 1.9 | 1.9 | 66% |
|
| Ratios | ZJYL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 30.2% | 59.1% | 35% |
|
| Net Margin | 5.8% | (7.7%) | 51% |
|
| ROA | 2.4% | (13.7%) | 58% |
|
| ROE | 4.1% | (15.9%) | 42% |
|
| Liabilities to Assets | 44.6% | 44.9% | 35% |
|
| F-Score | 5 | 4 | 51% |
|
Jin Medical International Ltd. did not pass any screens on 7/30/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors